慢阻肺急性加重期胶原降解与形成较稳定期升高
这项前瞻性多中心观察研究纳入498例GOLD 2至4级慢阻肺患者,在稳定期、急性加重期及加重后4周随访时检测血清胶原代谢标志物。结果显示C1M、C4M2、C4Ma3和Pro-C5从稳定期到加重期显著升高、随访时下降,且与气流受限、呼吸困难及加重时间相关。
要点
- 慢阻肺急性加重时血清胶原降解与形成标志物显著升高,随访下降。
- C1M、C4Ma3、Pro-C5与FEV1占预计值百分比呈显著负相关。
- C1M、C4Ma3、C4M2与未来加重时间独立相关。
核心结论
- 血清胶原重塑标志物与慢阻肺严重程度(气流受限、呼吸困难)及疾病结局(加重时间、BODE指数)显著相关。
研究设计与样本
- 前瞻性、观察性、多中心研究,纳入498例GOLD 2至4级慢阻肺患者。
- 在稳定期、急性加重期及加重后4周随访时检测血清ECM标志物。
主要发现
- 稳定期FEV1占预计值百分比与C1M、C4Ma3、Pro-C5呈显著负相关。
- C1M、C4M2、C4Ma3、Pro-C5与BODE指数及mMRC评分相关。
- C1M、C4M2、C4Ma3、Pro-C5从稳定期到加重期显著升高,随访时下降。
- 上述标志物在重度加重期显著高于中度加重期。
- 校正BMI、mMRC、Charlson评分及FEV1占预计值百分比后,C1M、C4Ma3、C4M2对加重时间有显著影响;无标志物预测死亡。
临床怎么用
- 血清胶原重塑标志物可用于评估慢阻肺严重程度及急性加重风险。
- 动态监测C1M、C4Ma3、C4M2等或有助于识别高加重风险患者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The role of the extracellular matrix (ECM) structure and remodeling thereof in lung diseases is gaining importance. Pathology-related changes in ECM turnover may result in deleterious changes in lung architecture, leading to disease in the small airways. Here, degradation fragments of type I (C1M), type IV (α1 chain, C4M2), and type IV (α3 chain, C4Ma3) collagen, all degraded by metalloproteinases and the pro-form of collagen type V (PRO-C5) were investigated and associated with COPD severity and outcome. METHODS: In a prospective, observational, multicenter study including 498 patients with COPD Gold Initiative for Chronic Obstructive Lung Disease stage 2 to 4, ECM markers were assessed in serum at stable state, exacerbation, and at follow-up 4 weeks after exacerbation. RESULTS: At stable state, there was a significant inverse association between FEV1 % predicted and C1M, C4Ma3, and Pro-C5. C1M, C4M2, C4Ma3, and Pro-C5 were associated with BMI, airflow obstruction, dyspnea, and exercise capacity (BODE) index and the modified Medical Research Council (MMRC) score. C1M, C4M2, C4Ma3, and Pro-C5 were significantly increased from stable state to exacerbation and decreased at follow-up. Furthermore, the biomarkers were significantly higher during severe exacerbation compared with moderate exacerbation. Multivariate analysis adjusted for BMI, MMRC score, unadjusted Charlson score, and FEV1 %predicted showed a significant influence of C1M, C4Ma3, and C4M2 on time to exacerbation. None of the biomarkers were predictors for mortality. CONCLUSIONS: Serologically assessed collagen remodeling appears to play a significant role in COPD severity (airflow limitation, dyspnea) and disease outcome (time to exacerbation and prognosis as assessed by the BODE index).
引用
- Schumann DM, Leeming D, Papakonstantinou E, et al. Collagen Degradation and Formation Are Elevated in Exacerbated COPD Compared With Stable Disease. Chest. 2018. PMID: 29966667. doi:10.1016/j.chest.2018.06.028
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。